Breaking News Instant updates and real-time market news.

IDXG

Interpace Diagnostics

$1.01

-0.04 (-3.81%)

, LH

LabCorp

$170.58

-3.25 (-1.87%)

08:17
03/20/18
03/20
08:17
03/20/18
08:17

Interpace Diagnostics expands LabCorp national agreement

Interpace Diagnostics Group (IDXG) announced that the company has executed a new agreement with LabCorp (LH) to further expand the company's national network of cytology providers in support of its Thyroid molecular business unit. The arrangement builds on the parties' 2016 agreement, which established electronic ordering and result reporting through LabCorp for the Interpace's proprietary ThyGenX and ThyraMIR tests, which can provide physicians and patients with more specific diagnostic information about the presence of thyroid cancer in patients whose initial biopsy does not conclusively indicate whether a thyroid nodule is malignant or benign.Under the parties' new agreement, physicians will be able to order both thyroid biopsy analysis and molecular testing from Interpace. Dianon Pathology, a member of the LabCorp Specialty Testing Group, will be available to the biopsy analysis, and in the event of an indeterminate result, Interpace will then perform its molecular tests. In addition, physicians who order thyroid biopsy analysis services from Dianon can request an automatic reflex to Interpace's tests in the event of an indeterminate biopsy result, in which case Dianon will then automatically refer those samples to Interpace to perform the Company's proprietary assays, ThyGenX and ThyraMIR. Since Interpace first started offering integrated cytology services to customers, a significant percentage of cases ultimately deemed indeterminate have been referred to Interpace's molecular testing, providing physicians and patients with greater diagnostic clarity and reduced turnaround times, helping physicians and patients to more quickly learn whether there is a diagnosis of cancer, and allowing treatment to be commenced earlier when necessary.

IDXG

Interpace Diagnostics

$1.01

-0.04 (-3.81%)

LH

LabCorp

$170.58

-3.25 (-1.87%)

IDXG Interpace Diagnostics
$1.01

-0.04 (-3.81%)

08/15/17
MAXM
08/15/17
INITIATION
Target $5
MAXM
Buy
Interpace Diagnostics initiated with a Buy at Maxim
Maxim analyst Jason Kolbert initiated Interpace Diagnostics with a Buy and a $5 price target saying its endocrine and pancreatic cancer diagnostic tests, ThyGenX and ThyraMIR, are growth drivers, and enable physicians to optimize the clinical course of action for patients with indeterminate cancer cytology. Kolbert said the endocrine cancer diagnostics are worth upwards of $350M.
03/08/18
HCWC
03/08/18
INITIATION
Target $3
HCWC
Buy
Interpace Diagnostics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Interpace Diagnostics with a Buy rating and $3 price target. The company's diagnostic offerings are differentiated in that PancraGEN has a positive predictive value significantly better than international guidelines for diagnosis of pancreatic malignancy, Selvaraju tells investors in a research note.
03/08/18
03/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyler Technologies (TYL) initiated with a Neutral at DA Davidson. 2. Interpace Diagnostics (IDXG) initiated with a Buy at H.C. Wainwright. 3. Crispr Therapeutics (CRSP) initiated with an Outperform at JMP Securities. 4. Quanta Capital Hldgs (QNTA) initiated with an Outperform at Northland. 5. Genocea (GNCA) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LH LabCorp
$170.58

-3.25 (-1.87%)

02/07/18
CHLM
02/07/18
NO CHANGE
Target $204
CHLM
Buy
LabCorp price target raised to $204 from $180 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for LabCorp to $204 from $180 following better than expected Q4 results. The analyst reiterates a Buy rating on the shares.
02/26/18
LEHM
02/26/18
NO CHANGE
Target $210
LEHM
Overweight
LabCorp price target raised to $210 from $195 at Barclays
Barclays analyst Jack Meehan raised his price target for Laboratory Corp. of America to $210 ahead of the company's analyst day. The analyst believes the company's "value proposition creates a compelling valuation case for the stock." He expects LabCorp to show proof points that its global life science strategy can deliver value to customers and shareholders. Meehan keeps an Overweight rating on the shares.
03/14/18
03/14/18
UPGRADE
Target $103

Equal Weight
Quest Diagnostics upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded Quest Diagnostics (DGX) to Equal Weight from Underweight, noting that the stock's valuation has "drifted back" toward that of peer LabCorp (LH) and he now sees the risk/reward as balanced. While PAMA reimbursement cuts are a multiyear headwind to earnings, the impact appears to be reflected in Quest Diagnostics' share price, contends Goldwasser, who raised his price target on the stock to $103 from $95.
03/19/18
ADAM
03/19/18
NO CHANGE
Target $115
ADAM
Buy
UnitedHealth contract a potential NT catalyst for Quest, says Canaccord
Canaccord analyst Mark Massaro raised his price target on Quest Diagnostics (DGX) to $115 from $113 following investor meetings with Shawn Bevec, Quest's Executive Director of IR. Massaro, who reiterated a Buy rating, views Quest as an underappreciated large cap "cash cow" well positioned to consolidate labs, particularly in the $48B hospital lab market, where he says it has a "competitive edge" over LabCorp (LH). Additionally, Massaro said the fate of the UnitedHealth (UNH) contract, an exclusive to LabCorp but is set to expire at the end of the year, remains a potential near-term positive catalyst for Quest, noting that Quest is in "active dialogue" with UnitedHealth executives at the highest levels" and at Optum. Though UnitedHealth could renew the deal with LabCorp, Massaro believes it is likely that the contract will open up to both LapCorp and Quest.

TODAY'S FREE FLY STORIES

DLR

Digital Realty

$115.95

-5.055 (-4.18%)

05:19
09/25/18
09/25
05:19
09/25/18
05:19
Syndicate
Digital Realty 8.5M share Secondary priced at $113.00 »

BofA/Merrill and Citi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 04

    Oct

  • 22

    Oct

  • 25

    Sep

SQ

Square

$86.06

0.75 (0.88%)

, FB

Facebook

$165.40

2.5 (1.53%)

05:18
09/25/18
09/25
05:18
09/25/18
05:18
Recommendations
Square, Facebook, Alphabet, Alphabet Class A, Amazon.com, Netflix analyst commentary  »

Square price target…

SQ

Square

$86.06

0.75 (0.88%)

FB

Facebook

$165.40

2.5 (1.53%)

GOOG

Alphabet

$1,173.38

7.17 (0.61%)

GOOGL

Alphabet Class A

$1,179.78

7.56 (0.64%)

AMZN

Amazon.com

$1,934.50

16.75 (0.87%)

NFLX

Netflix

$369.70

8.71 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 26

    Nov

  • 03

    Mar

VIOT

Viomi Technology

$0.00

(0.00%)

05:18
09/25/18
09/25
05:18
09/25/18
05:18
Syndicate
Viomi Technology 11.4M share IPO priced at $9.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

VCTR

Victory Capital

$9.50

0.45 (4.97%)

05:12
09/25/18
09/25
05:12
09/25/18
05:12
Upgrade
Victory Capital rating change  »

Victory Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

  • 10

    Oct

IRET

Investors Real Estate

$5.58

-0.03 (-0.53%)

05:11
09/25/18
09/25
05:11
09/25/18
05:11
Upgrade
Investors Real Estate rating change  »

Investors Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCCI

Heritage-Crystal Clean

$20.40

-0.15 (-0.73%)

05:10
09/25/18
09/25
05:10
09/25/18
05:10
Upgrade
Heritage-Crystal Clean rating change  »

Heritage-Crystal Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 01

    Oct

GHDX

Genomic Health

$70.84

1.65 (2.38%)

, LH

LabCorp

$169.54

-2.46 (-1.43%)

05:09
09/25/18
09/25
05:09
09/25/18
05:09
Recommendations
Genomic Health, LabCorp, Myriad Genetics, Natera, Quest Diagnostics analyst commentary  »

Piper sees early winners…

GHDX

Genomic Health

$70.84

1.65 (2.38%)

LH

LabCorp

$169.54

-2.46 (-1.43%)

MYGN

Myriad Genetics

$46.91

0.64 (1.38%)

NTRA

Natera

$23.83

-0.35 (-1.45%)

DGX

Quest Diagnostics

$107.61

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

  • 27

    Nov

WK

Workiva

$37.20

0.65 (1.78%)

05:08
09/25/18
09/25
05:08
09/25/18
05:08
Upgrade
Workiva rating change  »

Workiva upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CY

Cypress Semiconductor

$15.52

-0.45 (-2.82%)

05:07
09/25/18
09/25
05:07
09/25/18
05:07
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLAR

Clarus Corporation

$10.45

-0.3 (-2.79%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Clarus Corporation management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AMSC

AMSC

$6.33

-0.265 (-4.02%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AMSC management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NNBR

NN, Inc.

$15.65

-0.05 (-0.32%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

LBTYA

Liberty Global

$28.37

-0.87 (-2.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Liberty Global management to meet with Wolfe Research »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

TRU

TransUnion

$73.68

-0.62 (-0.83%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TransUnion management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

TSLX

TPG Specialty Lending

$20.56

-0.15 (-0.72%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

THR

Thermon Group

$25.98

-0.14 (-0.54%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

September Richmond Fed…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AdvaMed to hold a conference »

MedTech Conference will…

IMPV

Imperva

$46.70

1.05 (2.30%)

, FIVN

Five9

$43.51

0.3 (0.69%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$46.70

1.05 (2.30%)

FIVN

Five9

$43.51

0.3 (0.69%)

CDAY

Ceridian

$42.29

0.225 (0.53%)

MSFT

Microsoft

$114.72

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

TEN

Tenneco

$44.59

-0.9 (-1.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Tenneco management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Oct

SWCH

Switch

$10.85

-0.21 (-1.90%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SRNE

Sorrento Therapeutics

$4.23

-0.075 (-1.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Sorrento Therapeutics management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$78.75

2.44 (3.20%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Exact Sciences management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KRYS

Krystal Biotech

$17.68

0.8 (4.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Krystal Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

GMED

Globus Medical

$54.09

-0.04 (-0.07%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Globus Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.